(Q72142546)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7710739%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

title

Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7710739%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7710739%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

4

W Danysz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7710739%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1

G Skuza

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7710739%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

author name string

G Quack

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7710739%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7710739%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7710739%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7710739%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

page(s)

57-67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7710739%20AND%20SRC:MED&resulttype=core&format=json

Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.

24 October 2019

cites work

1 reference

12 December 2020

Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on N-methyl-D-aspartate-evoked acetylcholine release in the rabbit caudate nucleus in vitro

1 reference

12 December 2020

Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior

1 reference

12 December 2020

Behavioural pharmacology of glutamate in the basal ganglia

1 reference

12 December 2020

NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats

1 reference

12 December 2020

Blockade of N-methyl-D-aspartate receptors potentiates dopaminergic responses in the 6-OHDA model of Parkinson: differential role of D-1 and D-2 receptors

1 reference

12 December 2020

Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice

1 reference

12 December 2020

Studies on the mechanism of action of the antiparkinsonian drugs memantine and amantadine: no evidence for direct dopaminomimetic or antimuscarinic properties

1 reference

12 December 2020

Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801

1 reference

12 December 2020

Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice

1 reference

12 December 2020

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

1 reference

12 December 2020

Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.

1 reference

12 December 2020

The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way

1 reference

12 December 2020

The effect of adding amantadine to optimum L-dopa dosage in Parkinson's syndrome

1 reference

12 December 2020

Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity

1 reference

12 December 2020

Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

1 reference

12 December 2020

Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats

1 reference

12 December 2020

An interim report of the effect of selegiline (L-deprenyl) on the progression of disability in early Parkinson's disease. The Parkinson Study Group

1 reference

12 December 2020

Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease.

1 reference

12 December 2020

Current status of dopamine agonists in Parkinson's disease management

1 reference

12 December 2020

Excitotoxicity of L-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases

1 reference

12 December 2020

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

1 reference

12 December 2020

N-Methyl-d-Aspartate Antagonists in the Treatment of Parkinson's Disease

1 reference

12 December 2020

Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats?--case of amantadine and memantine

1 reference

12 December 2020

Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity

1 reference

12 December 2020

Pharmacological basis of the therapeutic effect of (-)deprenyl in age-related neurological diseases

1 reference

12 December 2020

1 reference

12 December 2020

Deprenyl suppresses the oxidant stress associated with increased dopamine turnover

1 reference

12 December 2020

Current drug therapy for Parkinson's disease. A review

1 reference

12 December 2020

Effect of amantadine on chlorpromazine and reserpine-induced behavioral depression in the mouse

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01277594

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7710739%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference